IRIS
SARAO, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.656
AS - Asia 2.431
EU - Europa 1.207
SA - Sud America 465
AF - Africa 54
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.576
SG - Singapore 1.202
CN - Cina 458
BR - Brasile 380
IT - Italia 282
HK - Hong Kong 231
VN - Vietnam 208
UA - Ucraina 174
DE - Germania 149
RU - Federazione Russa 138
FR - Francia 111
BD - Bangladesh 91
IE - Irlanda 72
FI - Finlandia 69
GB - Regno Unito 64
IN - India 52
TR - Turchia 50
CA - Canada 46
AR - Argentina 34
SE - Svezia 32
NL - Olanda 25
IQ - Iraq 21
AT - Austria 20
PL - Polonia 19
KR - Corea 18
JP - Giappone 17
MX - Messico 17
BE - Belgio 15
EC - Ecuador 14
ZA - Sudafrica 13
ID - Indonesia 12
PK - Pakistan 12
CO - Colombia 9
UZ - Uzbekistan 9
PY - Paraguay 8
SA - Arabia Saudita 8
CL - Cile 6
ES - Italia 6
KE - Kenya 6
MA - Marocco 6
AU - Australia 5
EG - Egitto 5
TG - Togo 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
JO - Giordania 4
LT - Lituania 4
OM - Oman 4
PE - Perù 4
PH - Filippine 4
PS - Palestinian Territory 4
VE - Venezuela 4
AZ - Azerbaigian 3
BO - Bolivia 3
CH - Svizzera 3
HN - Honduras 3
KZ - Kazakistan 3
PT - Portogallo 3
RO - Romania 3
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
IS - Islanda 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MY - Malesia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BF - Burkina Faso 1
BJ - Benin 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GL - Groenlandia 1
GY - Guiana 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
MT - Malta 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
Totale 8.812
Salva come PNG Salva come JPEG
Città #
Ashburn 505
Singapore 493
Fairfield 428
Woodbridge 378
Chandler 360
Ann Arbor 283
Houston 248
Beijing 233
Hong Kong 226
San Jose 182
Seattle 170
Wilmington 157
Cambridge 132
Boardman 117
Council Bluffs 109
Jacksonville 95
Lauterbourg 83
Dearborn 75
Dublin 72
Los Angeles 72
Princeton 72
Ho Chi Minh City 60
New York 55
Izmir 45
Dallas 44
Hanoi 40
Buffalo 38
Udine 37
Redondo Beach 35
Santa Clara 34
Munich 27
São Paulo 27
Ogden 26
San Diego 25
Norwalk 23
Dong Ket 22
Helsinki 22
Frankfurt am Main 21
Hefei 18
Warsaw 18
Seoul 17
The Dalles 17
Orem 16
Chicago 15
Des Moines 15
Brussels 14
Phoenix 14
Toronto 14
Belluno 13
Düsseldorf 12
Milan 12
Mumbai 12
Stockholm 12
Belo Horizonte 11
Brooklyn 11
Denver 11
Montreal 11
Porto Alegre 11
Rio de Janeiro 11
Wuhan 11
Amsterdam 10
Shenzhen 10
Vienna 10
Falls Church 9
Manchester 9
Rome 9
Tokyo 9
Bologna 8
Da Nang 8
Lappeenranta 8
Naples 8
Nuremberg 8
Ottawa 8
Redmond 8
Tashkent 8
Atlanta 7
Baghdad 7
Guangzhou 7
Mexico City 7
Nanjing 7
Paese 7
Shanghai 7
Treviso 7
Boston 6
Brasília 6
Chengdu 6
Curitiba 6
Hangzhou 6
Johannesburg 6
Quito 6
San Francisco 6
Turin 6
Bắc Ninh 5
Campinas 5
Chennai 5
Grafing 5
Hyderabad 5
Lomé 5
London 5
Nairobi 5
Totale 5.647
Salva come PNG Salva come JPEG
Nome #
Triamcinolone acetonide for the treatment of diabetic macular oedema 220
A case of CRB1-negative Coats-like retinitis pigmentosa 191
Comparison of short-wavelength blue-light autofluorescence and conventional blue-light autofluorescence in geographic atrophy 184
Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy 182
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors 169
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 167
Neovascular age-related macular degeneration 166
Proliferative Diabetic Retinopathy: Treatment Update 165
Fluocinolone acetonide for the treatment of diabetic macular edema 164
Dexamethasone implant in diabetic macular edema in real-life situations 161
Online optical coherence tomography during subthreshold laser irradiation 159
Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia 153
Author’s response 151
Pharmacotherapy for treatment of retinal vein occlusion. 150
One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: A prospective study 150
Optical coherence tomography angiography findings in diabetic retinopathy 149
Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes 149
New advances in retina: A report from the International Symposium on Ocular Pharmacology and Therapeutics meeting 142
Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema 139
Update on combination therapy in wet age-related macular degeneration 136
A comparison between a white LED confocal imaging system and a conventional flash fundus camera using chromaticity analysis 130
A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment 127
Drug safety evaluation of intravitreal triamcinolone acetonide 125
Macular pucker 124
Safety of 6000 intravitreal dexamethasone implants 124
Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 121
Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery 120
Intravitreal steroids for the treatment of retinal diseases. 118
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 118
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome 117
Faricimab in Neovascular AMD Complicated by Pigment Epithelium Detachment: An AI-Assisted Evaluation of Early Morphological Changes 114
The Present and Future of Optic Pathway Glioma Therapy 113
Regression of diabetic macular edema after subcutaneous exenatide. 113
Scleral fixation of a single-piece foldable acrylic IOL through a 1.80 mm corneal incision 113
Surgical Management for Diabetic Macular Edema 109
Aflibercept 2 mg biosimilar (Tyalia)—real-world experience from IRAN (ATRIA study) 109
Steroids in a Combination Strategy 107
Ocular Findings in {COVID}-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye 107
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice 107
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular edema: the UDBASA study 106
Delayed rhegmatogenous retinal detachment post macular surgery - a multicentric study 106
Green emission fluorophores in eyes with atrophic age-related macular degeneration: A colour fundus autofluorescence pilot study 100
Correction to: Fundamental principles of an effective diabetic retinopathy screening program (Acta Diabetologica, (2020), 57, 7, (785-798), 10.1007/s00592-020-01506-8) 99
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 98
Combination Therapy for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Anti-VEGF Monotherapy. Intravitreal Bevacizumab and Triamcinolone Acetonide 93
Automated diabetic retinopathy detection with two different retinal imaging devices using artificial intelligence: a comparison study 92
Choriocapillaris and outer choroid blood flow in acute central serous chorioretinopathy: a swept source OCT angiography study 90
Behind the mask: a critical perspective on the ethical, moral, and legal implications of AI in ophthalmology 84
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers 83
Biosimilar ranibizumab (BS1) – early experience from Japan (BRIJ study) 82
Edema maculare post occlusione venosa 81
Stem cell therapy in retinal diseases: current evidence 80
Impact on quality of life 80
Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression 80
Validation of Esaso Classification of Diabetic Maculopathy 77
Chromaticity analysis comparing a white light confocal imaging device versus a flash fundus camera 77
Fundamental principles of an effective diabetic retinopathy screening program 76
Choroidal Thickness Influences Green Emission Autofluorescence Component Intensity in Eyes with Geographic Atrophy Due to Age-Related Macular degeneration: A Color Fundus Autofluorescence Study 76
Present Status of Laser Therapy: Role of Subthreshold Laser 74
Early intraocular pressure dynamics following aflibercept 8 mg versus aflibercept 2 mg: a propensity score-matched analysis 73
Does lens influence green component in short 450 nm color autofluorescence? A cross-sectional study in heathy Caucasian population 72
Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options 71
Explainable artificial intelligence model for the detection of geographic atrophy using colour retinal photographs 70
Update on coronavirus disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination 70
Enhancing Diabetic Macular Edema Treatment Outcomes: Exploring the ESASO Classification and Structural OCT Biomarkers 68
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI) 68
One-year efficacy of anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration: a meta-analysis and meta-regression 66
Intravitreal Aflibercept for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Ranibizumab Therapy 62
Lens fogging comment on “Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy” 61
Twelve months outcomes of Intravitreal aflibercept for neovascular age-related macular degeneration. Fixed versus as needed dosing 60
Intravitreal Bevacizumab for Choroidal Neovascularization due to Pathological Myopia: Long-term Outcomes 60
The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey 59
Screening performance of an automated image analysis software for the detection of diabetic retinopathy using a conventional fundus photography or a confocal white LED device: a comparison study 59
Does the presence of vitreo-macular adhesion influence the outcome of antivascular endothelial growth factor therapy in patients with neovascular agerelated macular degeneration? Systematic review and meta-analysis 59
Long-term outcomes after intravitreal dexamethasone treatment in steroid responders 59
INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA UNRESPONSIVE TO ANTI-VEGF THERAPY 59
State-of-the art pharmacotherapy for non-neovascular age-related macular degeneration 58
Macular Holes 58
Response to: New norms in ophthalmic surgery during the COVID-19 pandemic: A narrative review from a Malaysia tertiary eye care center 57
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study 57
OCT angiography in chronic central serous chorioretinopathy 56
Long-term Effect of Intravitreal Bevacizumab on Chorioretinal Atrophy Progression in Myopic Choroidal Neovascularization 55
Response to: Should we establish a new normality for ophthalmic training in the COVID-19 pandemic? 54
Ranibizumab in neovascular age-related macular degeneration: an as-needed treatment regimen with bimonthly evaluation 52
Twelve-month treatment with intravitreal dexamethasone implant for diabetic macular edema 51
RWC Update: Different Surgical Techniques for Macular Hole Associated With Retinal Detachment; Diabetic Macular Edema – How Do You Treat Patients With Good Visual Acuity?; Benign Familial Fleck Retina 49
From pro-re-nata to fixed-interval regimen: evolving real-world treatment paradigms in anti-VEGF therapy for neovascular AMD 49
One-year outcomes of dexamethasone implant versus oral acetazolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa 45
Response to:Letter to the editor: Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 39
AI-Assisted OCT Clinical Phenotypes of Diabetic Macular Edema: A Large Cohort Clustering Study 37
AI-assisted analysis of early fluid dynamics following aflibercept 8 mg in treatment-naïve neovascular AMD 33
Aflibercept 2 mg Biosimilar (aflibercept-ayyh, Pavblu): Experience of safety in clinical settings-APEX- safety study 24
FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings – FORCE study 23
RWC Update: Intraocular Inflammation and Retinal Pharmacotherapy; Giant Retinal Tear; ILM Peeling in Myopic Macular Schisis 14
Immediate Sequential Bilateral Cataract Surgery: Are We Overstating the Case? [Letter] 11
Optical coherence tomography biomarkers in patients with diabetic macular edema treated with dexamethasone implants 3
Totale 9.118
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.259
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 0 0 0 0 0 0 53
2021/2022451 22 26 9 7 14 22 35 23 18 84 101 90
2022/2023758 96 51 7 121 82 179 0 71 97 4 31 19
2023/2024261 46 17 7 6 35 30 11 26 37 15 2 29
2024/20251.560 27 97 100 76 27 51 113 68 183 138 246 434
2025/20263.329 322 409 276 355 472 204 306 116 192 272 259 146
Totale 9.118